Modified Pemberton osteotomy for developmental dysplasia of the hip in children: a mid- to long-term follow-up study
Frontiers in Pediatrics · 09.06.2026 · 14
DOI: 10.3389/fped.2026.1841163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pediatrics, online erschienen am 09.06.2026. Verfasst von Ting Lei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Orthopedic Department, Hunan Children's Hospital (The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University), Changs…. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hunan Province.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background and objective Developmental dysplasia of the hip (DDH) is a common pediatric condition requiring timely surgical intervention in older children. Conventional Pemberton osteotomy, while effective, carries a risk of iatrogenic injury to the triradiate cartilage due to its blind deep-pericapsular trajectory. The modified Pemberton osteotomy (MPO) shifts the osteotomy endpoint to 3–5 mm above the sciatic notch, creating a greenstick hinge above the Y-shaped cartilage to avoid growth-plate damage. This study aimed to evaluate the mid- to long-term efficacy and safety of MPO in children with DDH over a minimum follow-up of 5 years. Materials and methods We retrospectively reviewed 55 patients (71 hips) who underwent open reduction combined with MPO between May 2004 and June 2025. Radiographic parameters included acetabular index (AI), central-edge angle (CEA), and Reimer index (RI). Clinical and radiographic outcomes were assessed using McKay criteria and Severin classification, respectively.
Results
The mean follow-up duration was 7.21±1.64 years. The mean AI improved from 39.66 ± 5.46° preoperatively to 12.71 ± 8.37° at final follow-up, demonstrating powerful and stable acetabular remodeling capacity. According to the McKay clinical criteria, highly satisfactory functional outcomes were achieved, with an excellent-good rate of 88.7% (63/71 hips). Radiographic assessment using the Severin classification confirmed excellent joint congruence, yielding an excellent-good rate of 93.0% (66/71 hips). Avascular necrosis (AVN) occurred in 8 hips (11.2%), which is a low and acceptable incidence compared to historical pelvic osteotomies.
Conclusion
MPO provides favorable and durable mid- to long-term clinical and radiographic outcomes for DDH in children. By avoiding iatrogenic injury to the triradiate cartilage, MPO offers improved surgical safety compared with conventional Pemberton osteotomy, with an acceptable AVN rate directly attributable to the procedure.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Orthopedic Department, Hunan Children's Hospital (The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University), Changsha, Hunan, China.
- The School of Pediatrics, University of South China, Changsha, Hunan, China.
- Hunan Provincial Key Laboratory of Pediatric Orthopedics, Changsha, Hunan, China.
Förderung
- Natural Science Foundation of Hunan Province
Zitieren
APA
Lei, T., Liu, K., Tang, J., Wu, J. Y., Tan, Q., Ye, W. H., Zhu, G. H., & Li, Y. Q. (2026). Modified Pemberton osteotomy for developmental dysplasia of the hip in children: a mid- to long-term follow-up study. Frontiers in Pediatrics, 14. https://doi.org/10.3389/fped.2026.1841163
Vancouver
Lei T, Liu K, Tang J, Wu JY, Tan Q, Ye WH, et al. Modified Pemberton osteotomy for developmental dysplasia of the hip in children: a mid- to long-term follow-up study. Frontiers in Pediatrics. 2026;14. doi:10.3389/fped.2026.1841163
BibTeX
@article{Lei2026,
author = {Lei, Ting and Liu, Kun and Tang, Jin and Wu, Jiang-Yan and Tan, Qian and Ye, Wei-Hua and Zhu, Guang-Hui and Li, Yu-Qing},
title = {Modified Pemberton osteotomy for developmental dysplasia of the hip in children: a mid- to long-term follow-up study},
journal = {Frontiers in Pediatrics},
year = {2026},
volume = {14},
doi = {10.3389/fped.2026.1841163}
}
EUVIMED